ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

MPH Mereo Biopharma Group Plc

26.50
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Mereo Biopharma Group Plc LSE:MPH London Ordinary Share GB00BZ4G2K23 ORD GBP0.003 (REG S)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 26.50 26.00 27.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Q3 Trading Update

21/01/2004 7:00am

UK Regulatory


RNS Number:4586U
Marchpole Holdings PLC
21 January 2004


 For Immediate Release                                    21 January 2004


                             Marchpole Holding plc

             Q3 Trading Update for the 3 Months Ended December 2003

                     "Continued Progress at Marchpole"

Marchpole Holdings plc, which designs, produces and sells high quality clothing
and accessories for the YSL and Boateng brands, today announces Q3 trading
performance ahead of Director's expectations.

Strong demand for both the YSL and Boateng brands produced sales for the third
quarter of #4.7m with operating profits of #393,000. Cumulative operating
profits for the nine months to end December 2003 are #1.2m versus a loss for the
comparable period last year of #0.6m.

Chief Executive, Greg Tufnell commented:

"With the retail picture uncertain I am delighted that we have completed the
Autumn Winter season with strong sell throughs and a fully delivered order book.
The 4th quarter is our strongest and the new season deliveries are progressing
well with forward order books for Spring Summer now approaching #12.0m."

For further information please contact:

Marchpole:                                           020 7908 7777
Greg Tufnell, Chief Executive
Justin Hampshire, Finance Director

Buchanan Communications:                             020 7466 5000
Tim Thompson / Nicola Cronk




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

TSTKBLFLZFBBBBV

1 Year Mereo Biopharma Chart

1 Year Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

1 Month Mereo Biopharma Chart

Your Recent History

Delayed Upgrade Clock